Cyclerion Therapeutics, Inc. (CYCN) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 4.1M |
| Enterprise Value | 855,750 |
| P/E Ratio | -2.26 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 9.58 |
| Price/Book Ratio | 3.25 |
| Enterprise/Revenue | 8.85 |
| Enterprise/EBITDA | -2.51 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -3.53 |
| Operating Margin | -3.59 |
| Return On Assets | -0.97 |
| Return On Equity | -0.88 |
| Revenue | 2.07M |
| Revenue/Share | 0.45 |
| Gross Profit | 2.07M |
| EBITDA | -3.53M |
| Net Income | -3.53M |
| Diluted EPS | -1.09 |
| Total Cash | 1.39M |
| Total Cash/Share | 0.33 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.82 |
| Book Value Per Share | 1.2 |
| 52-Week Change | 56.22 |
| 52-Week High | 8.48 |
| 52-Week Low | 1.03 |
| Moving Average 50 Days | 3.56 |
| Moving Average 200 Days | 2.42 |
| Average Volume | 27,077 |
| Shares Outstanding | 4.68M |
| % Held by Institutions | 3.85 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | May 16, 2023 |